Investigating the Physiology of Labour and Labour Onset Through Longitudinal Measurements Performed With a Wearable Sensor
1 other identifier
interventional
145
1 country
2
Brief Summary
The purpose of the study is to collect data to support the development and validation of a machine learning model for the automatic detection, prediction and monitoring of labour, through the use of a wearable sensor (Bloomlife sensor) that can be easily used at home. Women participating in the study will be asked to regularly record data with the Bloomlife sensor, from inclusion in the study until delivery. In addition, clinical information related to their pregnancy and delivery will be collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 5, 2019
CompletedFirst Submitted
Initial submission to the registry
May 20, 2019
CompletedFirst Posted
Study publicly available on registry
June 11, 2019
CompletedJune 11, 2019
June 1, 2019
8 months
May 20, 2019
June 10, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Accuracy
Accuracy of the machine learning model for the automatic detection of labor, measured in terms of sensitivity and specificity in detecting labour
At delivery
Secondary Outcomes (1)
Labour probability
At delivery
Study Arms (1)
Bloomlife
EXPERIMENTALInterventions
Women use the Bloomlife sensor to collect data throughout their pregnancy. The collected data is stored locally in the device, but it is not used to provide any feedback to the patients or to the clinical team. Therefore the use of the device doesn't have an impact on clinical decision making and patients' care.
Eligibility Criteria
You may qualify if:
- Pregnant
- Gestational age between 20 weeks and 0 days and 30 weeks and 0 days
- Willingness to participate in the study
You may not qualify if:
- Implanted pacemaker or any other implanted electrical device
- History of allergies to silicone-based adhesives
- Any health condition resulting in higher chance of C-section (meeting one of these criteria is sufficient to be excluded): previous history of C-section, placental abnormality, being primipara and older than 40
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Ziekenhuis Oost-Limburg
Genk, 3600, Belgium
CHR de la Citadelle
Liège, 4000, Belgium
Study Officials
- PRINCIPAL INVESTIGATOR
Wilfried Gyselaers, MD, PhD
Ziekenhuis Oost-Limburg
- PRINCIPAL INVESTIGATOR
Frederic Chantraine, MD, PhD
CHR de la Citadelle
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2019
First Posted
June 11, 2019
Study Start
March 30, 2018
Primary Completion
November 26, 2018
Study Completion
March 5, 2019
Last Updated
June 11, 2019
Record last verified: 2019-06